Scapho®150 mg Powder for Solution for Injection(SC)
Important note: Before prescribing, consult full prescribing information.
Presentation: Secukinumab. Powder for solution for subcutaneous injection containing 150 mg of secukinumab.
Plaque psoriasis: Treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.
Psoriatic arthritis: Treatment of active psoriatic arthritis in adult patients, alone or in combination with methotrexate (MTX), when the response to previous disease-modifying anti-rheumatic drug (DMARD) therapy has been inadequate.
Axial spondyloarthritis (axSpA) with or without radiographic damage:
Ankylosing spondylitis(AS) / axSpA with radiographic damage: Treatment of active ankylosing spondylitis in adults who have responded inadequately to conventional therapy.
Non-radiographic axial spondyloarthritis (nr-axSpA)/axSpA without radiographic damage: Treatment of adult patients with active non-radiographic axial spondyloarthritis with objective signs of inflammation.
Reference: Scapho BSS Sept 2019
Full Prescribing Information available upon request
NP4 Expiry date:
Saturday, December 31, 2022 - 12:11